Luizza 1.5/30 Tablet
Product Images NDC 70700-314

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Luizza 1.5/30 (NDC 70700-314). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Xiromed Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Ethinyl Estradiol And Norethindrone Acetate Structural Formulas (Image 01)

Ethinyl Estradiol And Norethindrone Acetate Structural Formulas (Image 01)
Chemical structures of norethindrone acetate and ethinyl estradiol are shown. Each structure includes molecular formula and molecular weight: norethindrone acetate (C22H28O3, MW 340.46) and ethinyl estradiol (C20H24O2, MW 296.40).*
FDA Label Image

Table Ii Circulatory Disease Mortality Rates Per 100,000 Woman Years By Age, Smoking Status And Oral Contraceptive Use (Image 02)

Table Ii Circulatory Disease Mortality Rates Per 100,000 Woman Years By Age, Smoking Status And Oral Contraceptive Use (Image 02)
A bar graph depicting mortality rates (number of deaths per 100,000 woman users) by age groups (15-24, 25-34, 35-44, 45+) for four categories: ever-users (non-smokers), controls (non-smokers), ever-users (smokers), and controls (smokers). The highest mortality rate is observed in ever-users (smokers) aged 45 and older.*
FDA Label Image

Figure 1: Relevant Studies Of Risk Of Breast Cancer With Combined Oral Contraceptives (Image 03)

Figure 1: Relevant Studies Of Risk Of Breast Cancer With Combined Oral Contraceptives (Image 03)
A forest plot chart comparing effect estimates (odds ratios, relative risks, hazard ratios) from studies on 'Ever COC vs. Never COC Use' and 'Current COC use vs. Never-Use.' The studies include NICHD Women’s Care, French E3N cohort, Shanghai Women’s Health, Nurses' Health, Oxford Family Planning, and Danish Sex Hormone Register from 2002 to 2017. The plot shows confidence intervals around the effect estimates on a horizontal scale from -1.5 to 2.0, with an axis labeled 'Effect Estimate.' Definitions of RR, OR, HR, and COC use categories are noted below the chart.*
FDA Label Image

Brief Summary Patient Package Insert Figure 1 (Image 04)

Brief Summary Patient Package Insert Figure 1 (Image 04)
An instructional diagram showing a three-week pill pack layout for Luizza 1.5/30 tablets (norethindrone acetate and ethinyl estradiol). Circles representing daily pills are arranged in rows labeled Week 1, Week 2, and Week 3, with days of the week from Sunday to Saturday indicated. Arrows and text guide correct pill start and direction of taking pills from left to right each week. The pack contains 21 tablets.*
FDA Label Image

Brief Summary Patient Package Insert Figure 2 (Image 05)

Brief Summary Patient Package Insert Figure 2 (Image 05)
This image shows day labels arranged in rows representing each day of the week from Monday to Sunday with alternating sequences. Below the labels, there is an instruction box detailing how to select the correct day label strip by matching it with the first day of a menstrual period and place it on a blister pack, starting with Sunday. The instructions note skipping the step if the first day is Sunday.*
FDA Label Image

Detailed Patient Package Insert Figure 1 (Image 06)

Detailed Patient Package Insert Figure 1 (Image 06)
An instructional diagram for Luizza 1.5/30 (norethindrone acetate and ethinyl estradiol) tablets showing a 3-week pill pack with 21 circled positions labeled by days of the week from Sunday to Saturday. Arrows indicate start points for Sunday starters and day-1 starters. Instructions guide users to place the day label strip and take pills from left to right each week. The pack includes storage information and NDC 70700-314.*
FDA Label Image

Detailed Patient Package Insert Figure 2 (Image 07)

Detailed Patient Package Insert Figure 2 (Image 07)
An instructional diagram for LUIZZA 1.5/30 tablets showing a day label strip with the days of the week arranged in rows, each row starting with a different weekday. It includes directions to align the day strip with the first day of the user's menstrual period to track daily tablet use, noting that if the first day is Sunday, the step can be skipped.*
FDA Label Image

Norethindrone Acetate And Ethinyl Estradiol Tablets Label (Image 08)

Norethindrone Acetate And Ethinyl Estradiol Tablets Label (Image 08)
Carton packaging label for Luizza 1.5/30 tablets containing norethindrone acetate 1.5 mg and ethinyl estradiol 30 mcg per tablet. The label shows the product as a prescription oral tablet with 3 pouches, each containing one blister pack of 21 tablets, manufactured by Xiromed LLC. The label includes NDC 70700-314 and dosage details clearly printed.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.